Acute Pain - Epidemiology Forecast - 2036

Key Highlights:

• Acute pain is a sudden, sharp, and short-term sensory response to tissue injury, illness, or medical procedures that serves as a warning signal to the body. It is mediated by nerve signals to the brain, varies in perception among individuals, and typically resolves once the underlying cause is treated, usually lasting from a few minutes to less than six months.
• Acute pain is typically defined as pain lasting less than six months, arising suddenly from injury, illness, or physiological events such as infection or menstrual cramps, and serving a protective function. In contrast, chronic pain persists beyond normal healing and is often linked to underlying conditions like arthritis or neuropathy. If not properly managed, acute pain can transition to chronic pain due to prolonged nociceptive stimulation and changes in the nervous system, highlighting the importance of timely diagnosis and effective treatment to prevent long-term complications.
• The total incident cases of acute pain in the United States are projected to grow at a steady CAGR over the forecast period 2022-2036, reflecting a gradual increase in patient burden driven by factors such as population growth, aging demographics, and rising prevalence of underlying conditions associated with pain.
• In 2025, Among the 7MM, the US accounted for the largest share of acute pain cases (~45%), while the EU4, the UK, and Japan contributed comparatively lower case volumes, with Japan reporting the lowest burden
• The total incident cases of acute pain in the 7MM comprised 181,208,000 cases in 2025 and are projected to rise by 2036.

Acute pain Epidemiology Forecast in the 7MM

• 2025 Incident Cases of Acute pain: ~181,208,000
• Acute pain Growth Rate (2026-2036): 0.4% CAGR

DelveInsight's 'Acute pain - Epidemiology Forecast - 2036' report delivers an in-depth understanding of the brain cancer, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Acute pain Understanding and Diagnosis

Acute pain Overview and Diagnosis

Pain is an unpleasant sensory experience linked to actual or potential tissue damage, which may be acute (sudden and short-term) or chronic (persistent), and varies across individuals due to differences in nerve signaling and brain response. It is evaluated through clinical assessment of symptoms, history, and pain characteristics, supported by investigations such as imaging and laboratory tests. Standardized pain scales either unidimensional (measuring intensity) or multidimensional (assessing functional and emotional impact) are used to accurately assess pain and guide effective management.

Acute pain Epidemiology

Key Findings from Acute pain Epidemiological Analysis and Forecast

• The total number of incident cases of acute pain in the 7MM were around 181,208,000 in 2025.
• The total incident cases of acute pain in the US were around 87,410,000 in 2025. These cases are anticipated to increase in the upcoming years.
• In 2025, approximately 13% of the incident cases of acute pain were reported in Germany.
• In 2025, type-specific incident cases of acute pain in the 7MM comprised 89,907,500; 44,622,400; and 139,849,200 cases for postoperative pain, trauma pain, and acute medical illness, respectively.
• In 2025, there were ~20%; ~15% and ~10% cases for mild, moderate and severe, respectively, in Japan out of 7MM.
• In Germany in 2025, approximately 20% of acute pain cases were classified as mild, 15% as moderate, and around 10% as severe out of 7MM.

Scope of the Report:

• The report covers a segment of an executive summary, a descriptive overview of Acute pain, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

Acute pain Patient Population Forecast

Report Key Strengths

• Epidemiology-based (epi-based) Bottom-up Forecasting
• 11-year Forecast
• Patient Burden Trends (by geography)

FAQs:

• What are the disease risks, burdens, and unmet needs of brain cancer? What will be the growth opportunities across the 7MM concerning the patient population with brain cancer?
• What is the historical and forecasted brain cancer patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy:

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders' perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.